HuCNS-SC

End of line for StemCells Inc., pioneering & controversial stem cell biotech

stemcellsinc-logo

A sad, but not surprising day for the stem cell field as the biotech StemCells, Inc. announced that it is winding down its operations after terminating its spinal cord injury trial called the Pathway Study. The data generated so far did not justify continuing the trial. StemCells, Inc. (stock symbol STEM) has struggled financially for …

End of line for StemCells Inc., pioneering & controversial stem cell biotech Read More »

WAFSF stem cell vision talks: Hinton, Tsukamoto, Klassen, Takahashi

Henry-Klassen

Recently I was at the World Alliance Forum in San Francisco (WAFSF), a great meeting on stem cells and regenerative medicine. WAFSF had some excellent talks and I saw one session on the use of stem cells to treat vision impairment that was particularly striking. World Alliance Forum in San Francisco (WAFSF) This session’s all-star lineup included Drs. David …

WAFSF stem cell vision talks: Hinton, Tsukamoto, Klassen, Takahashi Read More »

Interview with StemCells Inc. leadership on hot topics

GregSchiffman

StemCells Inc. is a top biotech company developing stem cell-based therapies. They have a deep pipeline that includes already ongoing trials for a variety of diseases. I invited company leadership to do an interview and they graciously accepted. Below is the interview with CFO Greg Schiffman (picture at left from LinkedIn) including what I thought …

Interview with StemCells Inc. leadership on hot topics Read More »